| Secondary |
| Drug Use For Unknown Indication |
24.2% |
| Product Used For Unknown Indication |
22.3% |
| Bipolar I Disorder |
17.0% |
| Depression |
7.6% |
| Anxiety |
7.2% |
| Bipolar Disorder |
2.4% |
| Hepatitis C |
2.0% |
| Multiple Sclerosis |
1.7% |
| Insomnia |
1.5% |
| Schizoaffective Disorder |
1.5% |
| Dementia With Lewy Bodies |
1.3% |
| Drug Toxicity |
1.3% |
| Hiv Infection |
1.3% |
| Neurosis |
1.3% |
| Pain |
1.3% |
| Parkinson's Disease |
1.3% |
| Vaginitis Bacterial |
1.3% |
| Abnormal Behaviour |
1.1% |
| Cognitive Disorder |
1.1% |
| Drug Abuse |
1.1% |
|
| Thrombocytopenia |
9.4% |
| Sudden Death |
8.2% |
| Toxicity To Various Agents |
8.2% |
| Haemorrhage |
7.1% |
| Pulmonary Arterial Hypertension |
7.1% |
| Speech Disorder |
7.1% |
| Premature Baby |
5.9% |
| Somnolence |
5.9% |
| Drug Exposure During Pregnancy |
4.7% |
| Intra-uterine Death |
4.7% |
| Depression |
3.5% |
| Limb Malformation |
3.5% |
| Neuroleptic Malignant Syndrome |
3.5% |
| Off Label Use |
3.5% |
| Suicide Attempt |
3.5% |
| Toxic Encephalopathy |
3.5% |
| Vaginitis Gardnerella |
3.5% |
| Cardio-respiratory Arrest |
2.4% |
| Cholestasis |
2.4% |
| Confusional State |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.9% |
| Depression |
13.8% |
| Drug Use For Unknown Indication |
13.3% |
| Anxiety |
9.3% |
| Ill-defined Disorder |
4.2% |
| Hypertension |
3.9% |
| Bipolar Disorder |
3.5% |
| Insomnia |
3.3% |
| Rheumatoid Arthritis |
2.8% |
| Schizophrenia |
2.8% |
| Prophylaxis |
2.7% |
| Parkinson's Disease |
2.6% |
| Pain |
2.5% |
| Psychotic Disorder |
2.4% |
| Hiv Infection |
2.1% |
| Bipolar I Disorder |
2.0% |
| Type 2 Diabetes Mellitus |
1.7% |
| Breast Cancer |
1.6% |
| General Anaesthesia |
1.5% |
| Back Pain |
1.2% |
|
| Vertigo |
14.3% |
| Weight Increased |
7.1% |
| Tremor |
6.5% |
| Vomiting |
6.5% |
| Cytolytic Hepatitis |
5.8% |
| Pulmonary Embolism |
5.8% |
| Suicide Attempt |
5.8% |
| Neutropenia |
5.2% |
| Vascular Purpura |
5.2% |
| Thrombocytopenia |
4.5% |
| Weight Decreased |
4.5% |
| Death |
3.9% |
| Renal Failure |
3.9% |
| Renal Failure Acute |
3.9% |
| Suicidal Ideation |
3.2% |
| White Blood Cell Count Decreased |
3.2% |
| Hospitalisation |
2.6% |
| Nausea |
2.6% |
| Phlebitis |
2.6% |
| Rash |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
76.9% |
| Drug Use For Unknown Indication |
15.4% |
| Abnormal Behaviour |
5.1% |
| Acute Lymphocytic Leukaemia |
2.6% |
|
| Traumatic Brain Injury |
44.4% |
| Death |
22.2% |
| Hypoxia |
11.1% |
| Oral Disorder |
11.1% |
| Toxicity To Various Agents |
11.1% |
|
